Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mittal, Naveen K
EMBARK, NCT04524390 / 2020-000974-22: Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai	Completed	2	75	Europe, US, RoW	Maralixibat, Formerly LUM001 and SHP625, Placebo	Mirum Pharmaceuticals, Inc.	Biliary Atresia	11/23	02/24
Patel, Neela K
S-CitAD, NCT03108846: Escitalopram for Agitation in Alzheimer's Disease	Active, not recruiting	3	187	Canada, US	Escitalopram, Lexapro, Placebo, non-applicable	JHSPH Center for Clinical Trials, National Institute on Aging (NIA)	Dementia	04/24	05/25
Mulavelil, rachel
No trials found